Interestingly, TIM3 expression specifically on primary microglia in the TME but not CD8+ TILs appears to be downregulated by GBM itself both in vitro and in vivo, resulting in impaired antigen specific activation of CD8+ T cells (193). The gene discussed is CD8A; the disease is glioblastoma.